14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.98 $159.34 Thursday, 25th Apr 2024 ALNY stock ended at $143.71. This is 0.0626% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.67% from a day low at $141.98 to a day high of $145.77.
90 days $141.98 $184.29
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Aug 15, 2023 $180.00 $181.67 $178.64 $180.13 359 810
Aug 14, 2023 $184.41 $184.41 $180.76 $181.35 648 307
Aug 11, 2023 $184.11 $187.45 $184.11 $185.79 350 871
Aug 10, 2023 $188.02 $189.54 $184.99 $185.03 318 773
Aug 09, 2023 $186.19 $186.67 $184.15 $186.36 367 471
Aug 08, 2023 $184.54 $186.90 $182.72 $184.84 487 244
Aug 07, 2023 $185.61 $186.03 $182.77 $184.29 427 528
Aug 04, 2023 $189.31 $189.31 $184.08 $185.58 560 539
Aug 03, 2023 $182.13 $192.29 $180.02 $190.10 623 552
Aug 02, 2023 $186.80 $187.50 $184.16 $187.01 618 142
Aug 01, 2023 $193.40 $194.50 $187.47 $189.05 488 446
Jul 31, 2023 $199.10 $200.17 $194.54 $195.40 394 701
Jul 28, 2023 $196.59 $200.00 $195.00 $199.29 330 719
Jul 27, 2023 $196.18 $196.54 $192.62 $194.87 631 578
Jul 26, 2023 $193.42 $195.24 $190.05 $194.94 447 915
Jul 25, 2023 $192.06 $195.13 $190.76 $193.46 685 827
Jul 24, 2023 $201.19 $202.46 $190.88 $192.32 757 185
Jul 21, 2023 $201.89 $202.36 $199.36 $200.07 296 919
Jul 20, 2023 $204.33 $206.57 $200.00 $201.44 440 405
Jul 19, 2023 $209.97 $210.56 $205.30 $205.32 412 762
Jul 18, 2023 $202.77 $210.76 $200.13 $208.42 599 693
Jul 17, 2023 $208.00 $218.88 $201.86 $202.83 1 234 048
Jul 14, 2023 $203.54 $203.88 $196.90 $197.10 497 845
Jul 13, 2023 $203.29 $205.37 $201.19 $203.88 456 715
Jul 12, 2023 $204.09 $207.40 $201.77 $201.90 489 811
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT